Secondary metformin monotherapy failure in individuals with type 2 diabetes mellitus.

Tracey M WeissKristy IglayTania GulatiSwapnil RajpathakLingfeng YangLawrence Blonde

Published in: BMJ open diabetes research & care (2021)

The observed frequency of secondary MM failure underscores the importance of the American Diabetes Association's recommendation for glycemic monitoring of at least every 6 months so that timely therapeutic adjustments can be made.

Keyphrases

type diabetes
glycemic control
cardiovascular disease
clinical trial
randomized controlled trial
insulin resistance
weight loss
study protocol